Back to all bills
S 1036119th CongressIn Committee
Improving Access to Addiction Medicine Providers Act
Introduced: Mar 13, 2025
Standard Summary
Comprehensive overview in 1-2 paragraphs
The Improving Access to Addiction Medicine Providers Act would amend the Public Health Service Act to allow fellowships under the Minority Fellowship Program (MFP) to be awarded for training in addiction medicine. In practical terms, it broadens the MFP to include addiction medicine as an eligible field for fellowships and adds related training in diagnosis to the program’s scope. The goal is to expand the workforce of qualified addiction medicine providers, with an emphasis on minority professionals, to improve access to addiction treatment and address disparities in care. The bill does not specify new funding; any funding would come through existing or future appropriations.
Key Points
- 1Expands the Minority Fellowship Program to include addiction medicine as an eligible field for fellowships.
- 2Adds “diagnosis” to the scope of topics related to fellowship training (in the relevant subsection).
- 3Keeps the overall framework of the MFP under the Public Health Service Act intact.
- 4Aims to increase access to addiction medicine providers, potentially improving care for individuals with substance use disorders.
- 5Introduced in the Senate by Senators Cornyn and Luján; status is introduced (no enacted provisions yet).
Impact Areas
Primary: Minority health professionals seeking addiction medicine fellowships and, by extension, patients needing addiction treatment from a diverse group of providers.Secondary: The addiction medicine workforce and healthcare delivery organizations that rely on addiction specialists; potential improvement in treatment access and outcomes for patients with substance use disorders.Additional: Financial implications depend on future appropriations; the bill itself does not specify new funding, so implementation would depend on Congress’ budgeting decisions and HHS administration of the MFP.
Generated by gpt-5-nano on Nov 1, 2025